MedPath

The impact of Allopurinol in acute myocardial infarctio

Phase 3
Conditions
myocardial infarction.
Acute transmural myocardial infarction of unspecified site
Registration Number
IRCT2014062916229N3
Lead Sponsor
Vice chancellor for research,, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
146
Inclusion Criteria

Patients with first acute STEMI who are candidates for fibrinolytic therapy
Exclusion criteria: Patients with firs acute STEMI who are candidates for Primary PCI, Patients with previous myocardial infarction or Primary valvular disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ST resolution (in milimeter). Timepoint: On arriving at the emergency department (before the intervention) and 90 minute after streptokinase adminsteration(intervention) in emergency department. Method of measurement: ECG.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath